Dimensional Fund Advisors LP Repare Therapeutics Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 13,265 shares of RPTX stock, worth $43,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,265

Previous 13,265 -0.0%

Holding current value

$43,111

Previous $43,000 4.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$3.02 - $4.7 $83,062 - $129,268	-27,504 Reduced 67.46%	13,265 $43,000
Q1 2024 May 10, 2024	SELL	$4.53 - $8.41 $14,939 - $27,736	-3,298 Reduced 7.48%	40,769 $192,000
Q4 2023 Feb 07, 2024	SELL	$3.22 - $11.79 $23,080 - $84,510	-7,168 Reduced 13.99%	44,067 $321,000
Q3 2023 Nov 09, 2023	SELL	$8.16 - $13.01 $29,433 - $46,927	-3,607 Reduced 6.58%	51,235 $618,000
Q2 2023 Aug 09, 2023	BUY	$8.63 - $12.53 $690 - $1,002	80 Added 0.15%	54,842 $580,000
Q1 2023 May 12, 2023	BUY	$9.32 - $15.06 $14,697 - $23,749	1,577 Added 2.97%	54,762 $538,000
Q4 2022 Feb 09, 2023	BUY	$12.5 - $18.13 $502,575 - $728,934	40,206 Added 309.78%	53,185 $782,000
Q3 2022 Nov 10, 2022	SELL	$11.57 - $15.59 $333,991 - $450,036	-28,867 Reduced 68.98%	12,979 $157,000
Q2 2022 Aug 12, 2022	SELL	$8.45 - $14.84 $67,304 - $118,200	-7,965 Reduced 15.99%	41,846 $585,000
Q1 2022 May 13, 2022	SELL	$11.38 - $21.88 $18,492 - $35,555	-1,625 Reduced 3.16%	49,811 $709,000
Q4 2021 Feb 09, 2022	BUY	$19.66 - $28.11 $239,753 - $342,801	12,195 Added 31.08%	51,436 $1.09 Million
Q3 2021 Nov 12, 2021	BUY	$25.71 - $35.24 $1.01 Million - $1.38 Million	39,241 New	39,241 $1.03 Million

Others Institutions Holding RPTX

# of Institutions

Shares Held

35.4M

Call Options Held

50K

Put Options Held

300

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $136M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Repare Therapeutics Inc. Transaction History